-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Core Scientific, Maintains $17 Price Target

Benzinga·05/09/2025 10:39:26
Listen to the news
Canaccord Genuity analyst Joseph Vafi maintains Core Scientific (NASDAQ:CORZ) with a Buy and maintains $17 price target.